LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 213 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $206,000 | -48.4% | 1,353 | -57.4% | 0.02% | -50.0% |
| Q1 2019 | $399,000 | -72.0% | 3,175 | -63.2% | 0.03% | -56.2% |
| Q1 2018 | $1,423,000 | +22.5% | 8,618 | +1.6% | 0.07% | +23.7% |
| Q4 2017 | $1,162,000 | +3.8% | 8,484 | +3.3% | 0.06% | -3.3% |
| Q3 2017 | $1,119,000 | +7.1% | 8,215 | -4.6% | 0.06% | +1.7% |
| Q2 2017 | $1,045,000 | +15.3% | 8,609 | +0.6% | 0.06% | +13.2% |
| Q1 2017 | $906,000 | -17.8% | 8,558 | -21.1% | 0.05% | -23.2% |
| Q4 2016 | $1,102,000 | -14.3% | 10,849 | -13.9% | 0.07% | -15.9% |
| Q3 2016 | $1,286,000 | -14.4% | 12,604 | +0.1% | 0.08% | -19.6% |
| Q2 2016 | $1,502,000 | +17.9% | 12,593 | +5.8% | 0.10% | +10.9% |
| Q1 2016 | $1,274,000 | – | 11,899 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |